Equities

Strides Pharma Science Ltd

Strides Pharma Science Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)893.35
  • Today's Change56.50 / 6.73%
  • Shares traded877.05k
  • 1 Year change+173.87%
  • Beta1.1398
Data delayed at least 15 minutes, as of Apr 23 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • STAR:NSI trading volume exceeds daily average by +81.82%
  • STAR:NSI price reached a new 52-week high of 880.70 at 12:30 BST
  • STAR:NSI price moved over -1.05% to 836.00

Key statistics

Strides Pharma Science Ltd (STAR:NSI) set a new 52-week high during today's trading session when it reached 900.00. Over this period, the share price is up 164.30%.
52-week range
Today
325.00Apr 24 2023900.00Apr 23 2024
Open840.00
High900.00
Low840.00
Bid893.35
Offer893.35
Previous close893.35
Average volume320.65k
Shares outstanding91.90m
Free float62.76m
P/E (TTM)--
Market cap77.53bn INR
EPS (TTM)-16.88
INR
Annual div (ADY)1.50
INR
Annual div yield (ADY)0.18%
Div ex-dateAug 04 2023
Div pay-dateSep 27 2023
Data delayed at least 15 minutes, as of Apr 23 2024 11:28 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.